ULTOMIRIS 300 mg


Concentrate for solution for infusion
scheduling status
S4
registration number
59/30.1/0014
What ULTOMIRIS 300 mg contains
Ravulizumab.
other ingredients
Sodium phosphate, monobasic monohydrate Sodium phosphate, dibasic heptahydrate Polysorbate 80 L-arginine Sucrose Water for injection.
Therapeutic classification
Immunosuppressants.
© 2026 SAHPRA. ALL RIGHTS RESERVED